1992
DOI: 10.1016/0167-4838(92)90410-f
|View full text |Cite
|
Sign up to set email alerts
|

Adenosine deaminase from Saccharomyces cerevisiae: kinetics and interaction with transition and ground state inhibitors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

1993
1993
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(3 citation statements)
references
References 21 publications
0
3
0
Order By: Relevance
“…It has also been shown that the presence of adenosine deaminase favors AdoHC hydrolysis in vitro (119). Yeast adenosine deaminase has been purified and characterized (156,164), but its role in AdoHC metabolism has not been studied. However, the conversion of adenosine to AMP by adenosine kinase could be involved in this metabolism.…”
Section: Methyl Cyclementioning
confidence: 99%
“…It has also been shown that the presence of adenosine deaminase favors AdoHC hydrolysis in vitro (119). Yeast adenosine deaminase has been purified and characterized (156,164), but its role in AdoHC metabolism has not been studied. However, the conversion of adenosine to AMP by adenosine kinase could be involved in this metabolism.…”
Section: Methyl Cyclementioning
confidence: 99%
“…4.4) is an important enzyme [1] of the purine metabolism which catalyses the irreversible deamination of adenosine and 2 0 -deoxyadenosine to inosine and 2 0 -deoxyinosine, respectively (scheme 1). This enzyme has been found in plants, bacteria [2], invertebrates [3], vertebrates [4] and mammals [5,6], including humans [7 -9]. ADA is present in many human tissues, but the highest levels have been found in lymph nodes, spleen and thymus [1].…”
Section: Introductionmentioning
confidence: 99%
“…ADA is an ubiquitous enzyme found in a wide variety of microrganisms [Lupidi et al, 1992a], plants, invertebrates [Ma and Fisher, 1968;Aikawa et al, 19771, and mammals [Lupidi et al, 1992b], including humans [ Daddona and Kelley, 1980;Daddona, 19811. The development of inhibitors, which are ground-state (erythro-9-(2-hydroxy-3-nonyl)adenine, EHNA 12, Ki = 7 X lo-' M) [Schaeffer and Schwender, 19741 and transition state (coformycin and deoxycoformycin, Ki = 10-1'-10-12 M) stable analogues of substrate, made possible a direct approach to the investigation of the factors responsible for transition-state stabilization [Frick et al, 1986;Weiss et al, 1987;Kurz et al, 1987aKurz et al, , 1992Kurz and Frieden, 1987;Kati and Wolfenden, 1989;Wilson et al, 19911. Interest in studying this enzyme has been recently stimulated by the discovery that ADA activity is related to the development of several diseases.…”
Section: Introductionmentioning
confidence: 99%